| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant
|
Saul, Allan
|
|
2005
|
23 |
23 |
p. 3076-3083
8 p.
|
artikel
|
| 2 |
Associations of daycare and school entry vaccination requirements with varicella immunization rates
|
Davis, Matthew M.
|
|
2005
|
23 |
23 |
p. 3053-3060
8 p.
|
artikel
|
| 3 |
Changing attitudes towards polio vaccination: a randomized trial of an evidence-based presentation versus a presentation from a polio survivor
|
Wilson, Kumanan
|
|
2005
|
23 |
23 |
p. 3010-3015
6 p.
|
artikel
|
| 4 |
Comparison of antigen-specific cellular immune responses between individual PBMCs and splenocytes
|
Xin, Ke-Qin
|
|
2005
|
23 |
23 |
p. 2954-2955
2 p.
|
artikel
|
| 5 |
Editorial Board/Aims and Scope
|
|
|
2005
|
23 |
23 |
p. IFC-
1 p.
|
artikel
|
| 6 |
Fasciola hepatica procathepsin L3 protein expressed by a baculovirus recombinant can partly protect rats against fasciolosis
|
Reszka, Natalia
|
|
2005
|
23 |
23 |
p. 2987-2993
7 p.
|
artikel
|
| 7 |
Immune responses to recombinants of the South African vaccine strain of lumpy skin disease virus generated by using thymidine kinase gene insertion
|
Wallace, David B.
|
|
2005
|
23 |
23 |
p. 3061-3067
7 p.
|
artikel
|
| 8 |
Induction of a Th2 immune response by co-administration of recombinant adenovirus vectors encoding amyloid β-protein and GM-CSF
|
Kim, Hong-Duck
|
|
2005
|
23 |
23 |
p. 2977-2986
10 p.
|
artikel
|
| 9 |
Interleukin-2 potentiates foot-and-mouth disease vaccinal immune responses in mice
|
Yadav, Shikha
|
|
2005
|
23 |
23 |
p. 3005-3009
5 p.
|
artikel
|
| 10 |
Models of Phase 1 vaccine trials: optimization of trial design to minimize risks of multiple serious adverse events
|
Saul, Allan
|
|
2005
|
23 |
23 |
p. 3068-3075
8 p.
|
artikel
|
| 11 |
Production of rabies neutralizing antibody in hen's eggs using a part of the G protein expressed in Escherichia coli
|
Motoi, Yurie
|
|
2005
|
23 |
23 |
p. 3026-3032
7 p.
|
artikel
|
| 12 |
Recombination and flavivirus vaccines: a commentary
|
Monath, Thomas P.
|
|
2005
|
23 |
23 |
p. 2956-2958
3 p.
|
artikel
|
| 13 |
Role of the N-linked glycans of the prM and E envelope proteins in tick-borne encephalitis virus particle secretion
|
Goto, Akiko
|
|
2005
|
23 |
23 |
p. 3043-3052
10 p.
|
artikel
|
| 14 |
Screening the whole genome of a pathogen in vivo for individual protective antigens
|
Stemke-Hale, Katherine
|
|
2005
|
23 |
23 |
p. 3016-3025
10 p.
|
artikel
|
| 15 |
Species-specificity of a murine immunocontraceptive utilising murine cytomegalovirus as a gene delivery vector
|
Smith, L.M.
|
|
2005
|
23 |
23 |
p. 2959-2969
11 p.
|
artikel
|
| 16 |
Subunit vaccine based on the p67 major surface protein of Theileria parva sporozoites reduces severity of infection derived from field tick challenge
|
Musoke, Antony
|
|
2005
|
23 |
23 |
p. 3084-3095
12 p.
|
artikel
|
| 17 |
The real cost of rabies post-exposure treatments
|
Goswami, Amlan
|
|
2005
|
23 |
23 |
p. 2970-2976
7 p.
|
artikel
|
| 18 |
Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level
|
Bracci, Laura
|
|
2005
|
23 |
23 |
p. 2994-3004
11 p.
|
artikel
|
| 19 |
Unexpected problem of the traditional approach to the addition of aluminium hydroxide to vaccine preparations
|
Timofeev, Andrei V.
|
|
2005
|
23 |
23 |
p. 2953-
1 p.
|
artikel
|
| 20 |
Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections
|
Swenson, Dana L.
|
|
2005
|
23 |
23 |
p. 3033-3042
10 p.
|
artikel
|
Tijdschrift beschrijving